Company overview
Basic information
Company name
Daimeda, UAB
Company code
163384768
VAT code
LT633847610
Registered address
Gargždai, Klaipėdos g. 16, LT-96135
Registration date
1996-06-07
Company age: 30 y. 3 mo.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Retail sale of pharmaceutical products
Ownership form
Private without foreign capital
Uždaroji akcinė bendrovė vaistinė "Daimeda"
Company code: 163384768
Address: Gargždai, Klaipėdos g. 16, LT-96135
VAT code: LT633847610
Download a detailed company report
Make confident decisions with all the information about Daimeda, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
Daimeda, UAB (company code 163384768) is an operational private limited liability company registered in 1996. It is a private business in the national private non-financial companies sector, with private ownership and governance described as CEO only. The company is classified as micro-sized. Its main activity under EVRK code G.47.73.00 is retail sale of pharmaceutical products. The company is based in Gargždai, Klaipedos g. 16, LT-96135, in Klaipedos r. sav., Klaipedos apskr.
In financial year 2025, Daimeda generated revenue of EUR 2.5K and recorded net profit of EUR 732 after losses in 2023 and 2024. Revenue increased strongly compared with the previous year and was also higher than two years earlier. The company’s equity remained negative at EUR 58.1K, while liabilities were EUR 58.2K and total assets EUR 152. Staff levels were stable at an average of 2 employees in 2023, 2024 and 2025, and so far in 2026 the average headcount has remained at 2. The company’s share capital is EUR 68.1K.
In financial year 2025, Daimeda generated revenue of EUR 2.5K and recorded net profit of EUR 732 after losses in 2023 and 2024. Revenue increased strongly compared with the previous year and was also higher than two years earlier. The company’s equity remained negative at EUR 58.1K, while liabilities were EUR 58.2K and total assets EUR 152. Staff levels were stable at an average of 2 employees in 2023, 2024 and 2025, and so far in 2026 the average headcount has remained at 2. The company’s share capital is EUR 68.1K.